A

Arrowhead Pharmaceuticals
D

ARWR

16.790
USD
-0.12
(-0.71%)
مغلق
حجم التداول
20,401
الربح لكل سهم
-3
العائد الربحي
-
P/E
-14
حجم السوق
2,318,706,304
أصول ذات صلة
ALNY
ALNY
-4.39
(-1.33%)
325.26 USD
C
CRSP
0.455
(0.88%)
52.120 USD
E
EDIT
0.02000
(0.78%)
2.57000 USD
I
IONS
-0.450
(-1.03%)
43.190 USD
MRNA
MRNA
0.195
(0.64%)
30.480 USD
N
NTLA
-0.020
(-0.19%)
10.710 USD
REGN
REGN
-0.69
(-0.13%)
546.88 USD
S
SGMO
0.00200
(0.38%)
0.53200 USD
S
SRPT
0.010
(0.06%)
18.200 USD
VRTX
VRTX
2.24
(0.49%)
459.27 USD
المزيد
الأخبار المقالات

العنوان: Arrowhead Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.